IBM, UnitedHealth Share Gains Contribute To Dow's 313-Point Climb

Dow Jones01:46

DJ IBM, UnitedHealth Share Gains Contribute To Dow's 313-Point Climb

This article was automatically generated by MarketWatch using technology from Automated Insights.

Buoyed by positive growth for shares of IBM and UnitedHealth, the Dow Jones Industrial Average is climbing Wednesday afternoon.

The Dow (Dow Jones Industrial Average) was most recently trading 313 points (0.6%) higher, as shares of IBM (International Business Machines Corp.) and UnitedHealth (UnitedHealth Group Inc.) have contributed to the index's intraday rally.

IBM's shares have gained $9.41, or 4.1%, while those of UnitedHealth are up $8.07, or 3.0%, combining for a roughly 108-point bump for the Dow.

Other components contributing significantly to the gain include Salesforce (Salesforce Inc.), American Express (American Express Co.), and NVIDIA Corp. (NVIDIA Corp.).

A $1 move in any one of the 30 components of the benchmark equates to a 6.16-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled February 25, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 25, 2026 12:46 ET (17:46 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment